Önder Bozdoğan

Önder Bozdoğan

Auto-generated profile, based on publicly available information

Önder Bozdoğan

University of Health Science, Gülhane Training and Research Hospital

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2017 in Case Reports in Pathology
Verified
Journal Article
Open access
PDF file
BABanu Ince Alkan
Banu Ince Alkan
OBOnder Bozdogan
Onder Bozdogan
MKMüjde Karadeniz
Müjde Karadeniz
NBNazan Bozdoğan
Nazan Bozdoğan
Primary cutaneous adenoid cystic carcinoma (PCACC) is a very rare malignancy. The differential diagnosis of PCACCs in pathology practice can be difficult and a group of primary and metastatic lesions, including adenoid basal cell carcinoma of the skin, should be considered in the differential diagnosis. Besides histomorphological clues, immunohistochemistry studies are very helpful in the differential diagnosis of PCACC. We report herein a case of PCACC with extensive immunohistochemical studies and review the literature from an immunohistochemistry perspective.

21 November 2021 in Joint Diseases and Related Surgery
Verified
Journal Article
Open access
PDF file
BOBirhan Oktaş
Birhan Oktaş
MÇMeriç Çırpar
Meriç Çırpar
EŞElif Şanlı
Elif Şanlı
ICİbRahim Deniz Canbeyli
İbRahim Deniz Canbeyli
ÖBÖnder Bozdoğan
Önder Bozdoğan
Joint Diseases and Related Surgery (JDRS), the official journal of the Turkish Joint Diseases Foundation, is an international, peer-reviewed, immediate open access journal. All published articles in JDRS has been free for everyone, without embargo, since 1990.

26 December 2019 in International Wound Journal
Verified
Journal Article
Closed access
PDF file
PUPinar Incel Uysal
Pinar Incel Uysal
NANeslihan Akdogan
Neslihan Akdogan
OBOnder Bozdogan
Onder Bozdogan
EOEsra Ozhamam
Esra Ozhamam
SCSeray Cakmak
Seray Cakmak
BYBasak Yalcin
Basak Yalcin

1 January 2020 in Polish Journal of Pathology
Verified
Journal Article
Open access
PDF file
OBOnder Bozdogan
Onder Bozdogan
EKElçin Kadan
Elçin Kadan
NBNazan Bozdogan
Nazan Bozdogan
MAML2 rearrangements have been previously described for hidradenomas and muco-epidermoid carcinomas (MEC). However, one report showed EWSR1 rearrangement in both tumours. In this study, EWSR1 and MAML2 translocation were investigated in hidradenomas and MECs. Specimens from thirteen MECs...

7 February 2023 in Indian Journal of Surgery
Verified
Journal Article
Closed access
PDF file
CÇCanbert Çelik
Canbert Çelik
ASAli Sapmaz
Ali Sapmaz
MKMurat Özgür Kiliç
Murat Özgür Kiliç
SESadettin Er
Sadettin Er
SÖSabri Özden
Sabri Özden
BYBülent Cavit Yüksel
Bülent Cavit Yüksel

7 October 2024 in The Turkish Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
CÖCoşkun Fırat Özkeçeci
Coşkun Fırat Özkeçeci
MAMeli̇ke Arslan
Meli̇ke Arslan
EBEdibe Gözde Başaran
Edibe Gözde Başaran
YEYasin Maruf Ergen
Yasin Maruf Ergen
ÖBÖnder Bozdoğan
Önder Bozdoğan
NBNecati Balamtekin
Necati Balamtekin
Background. ZFYVE19 mutation has been recently identified as one of the non-syndromic causes of cholestasis. It is associated with elevated gamma-glutamyl transferase levels and is likely a cause of neonatal-onset and intrahepatic cholestasis. Case. Here, we report a rare case of ZFYVE19 defect, confirmed by whole exome sequencing (WES). Our patient, who is currently 4 years old, presented to us at the age of 2 years with elevated levels of serum transaminases and bilirubin. WES revealed a homozygous ZFYVE19 mutation despite preserved synthetic liver function. This gene has recently been identified in the literature as a cause of non-classical progressive familial intrahepatic cholestasis (OMIM # 619849). Treatment with an appropriate dose of ursodeoxycholic acid resulted in the regression of elevated liver enzymes and itching. The patient’s body mass index progressively increased throughout the treatment period. No medication side effects were observed at any point. Currently, the patient remains asymptomatic during follow-up. Conclusion. We have identified the ZFYVE19 mutation as a variant that is not accompanied by any other symptoms. However, we have limited knowledge about the progression of the disease and are closely monitoring the patient for potential liver-related issues. Using WES in cases of undiagnosed liver enzyme elevations or cholestasis can help identify new genes and improve our understanding of the underlying pathophysiology.